drugset / Trial / NCT01999764
Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a Phase IIa proof-of-concept study to evaluate the effects of oral QLT091001 on adults with impaired dark adaptation.
Timeline
- Start
- 2013-11
- Primary completion
- 2014-06
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zuretinol Acetate | Small molecule | 10 mg/m2 | Oral |
| Subject | Zuretinol Acetate | Small molecule | 40 mg/m2 | Oral |